Capricor Therapeutics, Inc. (CAPR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Capricor Therapeutics, Inc. (CAPR)
Company Performance

Current Price

as of Oct 16, 2024

$20.51

P/E Ratio

N/A

Market Cap

$667.37M

Description

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Metrics

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerCAPR
  • Price$20.51-5.05%

Trading Information

  • Market Cap$667.37M
  • Float83.22%
  • Average Daily Volume (1m)7,820,545
  • Average Daily Volume (3m)2,780,857
  • EPS-$0.93

Company

  • Revenue$27.15M
  • Rev Growth (1yr)1.38%
  • Net Income-$11.00M
  • Gross Margin91.01%
  • EBITDA Margin-282.88%
  • EBITDA-$11.23M
  • EV$127.64M
  • EV/Revenue4.70
  • P/EN/A
  • P/S24.05
  • P/B57.03
Documents